European Markets for Parkinson's Disease Therapeutics

Table of Contents

1. EXECUTIVE SUMMARY

Summary of Findings

• Summary

2. PARKINSON' S DISEASE

Disease Overview

• Scope
• Overview
• Prevalence and Incidence
• Clinical Classification
• Diagnosis

Treatment Overview

• Guidelines for Parkinson' s Disease Management
• Surgical and Related Options
• Product and Pricing Analysis

3. MARKET FOR PARKINSON' S DISEASE THERAPEUTICS

Market Engineering Analysis

• Market Overview
• Market Engineering Measurements

Market Dynamics

• Challenges
• Market Drivers
• Market Restraints

Market Forecasts and Trends

• Disease Progression
• Developments
• Patient Forecasts
• Revenue Forecasts

4. DOPAMINE AGONISTS MARKET

Current Drugs

• Dosage and Pricing Analysis
• Product Analysis

Market Dynamics

• Market Drivers
• Market Restraints

5. LEVODOPA/CARBIDOPA MARKET

Current Drugs

• Dosage and Pricing Analysis
• Product Analysis

Market Dynamics

• Market Drivers
• Market Restraints

6. OTHERS

Current Products and Pricing

• COMT Inhibitors
• MAO-B Inhibitors
• Fixed Dose Combinations

Market Dynamics

• Market Drivers
• Market Restraints

Pipeline Analysis

• Products in Phase III
• Products in Phase II

7. DECISION SUPPORT DATABASES

List of Tables

• Population Aged 65 Years and above
• Female Population Aged 65 Years and above
• Male Population Aged 65 Years and above
• Number of Physicians
• Hospital Discharge from Cerebrovascular Disease